Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Cleveland Heartlab Inc. is currently managing 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are split between 2 distinct art units and are being reviewed by 2 distinct examiners. SHELTON, SYNPHANE LA'SHAWN is one of the busiest examiners for the portfolio, with 1 pending case under their authority.
The distribution of 2 pending office actions across 2 distinct examiners and 2 distinct art units indicates a lack of concentration in the company's prosecution. Practitioners must navigate two different sets of examiner expectations and art unit standards within the Biotechnology & Pharmaceuticals field.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHELTON, SYNPHANE LA'SHAWN | 1 | 100.0% | +0.0% |
| MARTIN, PAUL C | 1 | 41.8% | +21.6% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18829111 | COMPOSITIONS AND METHODS FOR PURIFICATION AND DETECTION OF HDL AND APOAI | SHELTON, SYNPHANE LA'SHAWN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17588925 | Lp-PLA2 ASSAYS AND COMPOSITION WITH DETERGENT | MARTIN, PAUL C | — |
| Art Unit | Apps |
|---|---|
| 1652 | 1 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18829111 | COMPOSITIONS AND METHODS FOR PURIFICATION AND DETECTION OF HDL AND APOAI | SHELTON, SYNPHANE LA'SHAWN | 1652 | §103 | Non-Final OA | — | Pending | Sep 09, 2024 |
| 17588925 | Lp-PLA2 ASSAYS AND COMPOSITION WITH DETERGENT | MARTIN, PAUL C | 1653 | §103 | Non-Final OA | — | Pending | Jan 31, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial